The ratio of Type 1 versus Type 2 CALR mutation in our study corresponds to that found in PMF and ET patients in Asian and European countries except for China, where this ratio is reversed i.e. Type 2 mutation is more prevalent in the Chinese population [31]. This evidence concerns the gene CALR and essential thrombocythemia.